SCHEMBL17248348

SCHEMBL17248348

c1ccc(-c2cccc(-c3ccc4c(c3)c3ccccc3n4-c3ccc4oc5ccccc5c4c3)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.43
PLA2G4A P47712 4/20 0.43
PLA2G10 O15496 1/20 0.43
KDM4E B2RXH2 2/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PRKDC P78527 3/20 0.39
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TSPO P30536 1/20 0.37
EDNRB P24530 1/20 0.35
EDNRA P25101 1/20 0.35
AHR P35869 1/20 0.35
PGR P06401 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16482273 1.00 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10KDM4EATM
SCHEMBL18266001 1.00 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10KDM4EATM
SCHEMBL18266015 1.00 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10KDM4EATM
SCHEMBL17166795 1.00 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10KDM4EATM
SCHEMBL17166705 1.00 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10KDM4EATM
SCHEMBL17228751 1.00 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10KDM4EATM
SCHEMBL20097828 1.00 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10KDM4EATM
SCHEMBL16482389 1.00 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10KDM4EATM
SCHEMBL18266000 1.00 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10KDM4EATM
SCHEMBL17166622 1.00 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10KDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10361378-B2 Organic electroluminescent device NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2019-07-23 US disclosed
US-9960356-B2 Organic electroluminescence device, lighting equipment and display device Konica Minolta, Inc. (JP) 2018-05-01 US disclosed
US-9960356-B2 Organic electroluminescence device, lighting equipment and display device Konica Minolta, Inc. (JP) 2018-05-01 US disclosed
EP-2671935-B1 ORGANIC ELECTROLUMINESCENCE DEVICE, LIGHTING EQUIPMENT AND DISPLAY DEVICE KONICA MINOLTA INC (JP) 2016-11-30 EP disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10361378-B2 Organic electroluminescent device ELF3, DDT, LEF1 PLA2G2A 4329/4885PLA2G4A 4258/4885PLA2G10 4578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.